Videos

ARASTEP Trial TT

Advancing Treatment for High-Risk Biochemical Recurrence Prostate Cancer: The ARASTEP Trial - Alexander Chehrazi-Raffle Details Zach Klaassen discusses the ARASTEP trial with Alex Chehrazi-Raffle. The trial focuses on patients with high-risk biochemical recurrence of prostate cancer, specifically those who show positive results on PSMA PET scans but are negative on conventional imaging. Dr. Chehrazi-Raffle explains that ARASTEP, a randomized phase 3 study, aims to evaluate the efficacy of combining androgen deprivation the...
The ARASTEP Study: Evaluating the Treatment of Biochemically Recurrent Disease in nmHSPC Patients- Alicia Morgans Details Oliver Sartor welcomes Alicia Morgans to discuss the Phase III ARASTEP trial. Dr. Morgans explains that ARASTEP targets high-risk biochemical recurrence in hormone-sensitive patients, requiring a positive PSMA PET scan for enrollment. The trial compares the efficacy of ADT alone versus ADT with darolutamide, alongside SBRT to visible lesions, aiming to prolong metastasis-free survival (MFS). Uniqu...